Medicilon Appoints Dr. Qingcong Lin As President of Medicilon Usa Corp

Mar 11, 2024•over 1 year ago

Position

President

Company

Medicilon

Qingcong Lin

LexingtonBiotechnologyHealth Care

Description

Medicilon officially appoints Dr. Qingcong Lin as President of Medicilon USA Corp, a significant step to deepen its global and strategic layout. Dr

Company Information

Company

Medicilon

Location

Lexington, Massachusetts, United States

About

Medicilon was established in 2004. It is a leading CRO specializing in comprehensive preclinical research and development services in the field of biomedicine. It has established a comprehensive service; technology platform, which integrates compound synthesis, compound activity screening, structural biology, CMC, pharmacodynamics evaluation, pharmacokinetics and toxicological safety evaluation. On November 5, 2019, Medicilon was officially listed on the Science and Technology Innovation Board, becoming the first pharmaceutical CRO company to be listed on the board (Stock Code: 688202.SH).

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months